BOSTON, Oct. 29 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received purchase orders for its MammoView(TM) line of surgical endoscopy instruments from University of California, San Diego Medical Center, San Diego California. UCSD Medical Center is highly regarded in the industry as it provides a significant amount of healthcare in San Diego. UCSD Medical Center operates a network of outpatient practices, free clinics and community-based services.
UCSD Medical Center was named among the best in the nation in six specialty areas, in addition to possessing eighty physicians who earned a place in San Diego Magazine's 2009 "Physicians of Exceptional Excellence." UCSD Medical Center is home to one of just 39 National Cancer Institute-designated Comprehensive Cancer Centers in the United States. Such centers are prominent among the leading institutions in the nation dedicated to scientific innovation and clinical excellence. UCSD is the only Comprehensive Cancer Center in San Diego and Imperial counties to have earned this honor.
"We are extremely pleased to be a supplier to such a distinguished medical institution that is one of the top health care providers in the United States. We believe that our MammoView line will be instrumental in serving UCSD Medical Center wellness initiatives," stated Bob Segersten, President of Solos Endoscopy, Inc.
Solos Endoscopy recently announced that the Company has taken the initial steps to get the CE Marking for its FDA approved MammoView(TM) line of surgical instruments. This will allow the MammoView(TM) line to be sold throughout the European Economic Union (EEU), which represents 30% or $94 Billion of the worldwide demand for medical instruments.
For more information on UCSD Medical Center, please visit: www.ucsd.edu
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office with its catalog of FDA Approved products. Additional information is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE Solos Endoscopy, Inc.
|SOURCE Solos Endoscopy, Inc.|
Copyright©2009 PR Newswire.
All rights reserved